Sort
261,768 grants matching “gene therapy”
Mechanisms of Effective Humoral Immune Responses to HIV-1
$1,198,484Mark Connors · National Institute Of Allergy And Infectious Diseases · ZIA · FY2018 · AI
Immunobiology and therapy of oral mucosal and salivary gland chronic graft-versus-host disease
$1,198,466Jacqueline Mays · National Institute Of Dental & Craniofacial Research · ZIA · FY2020 · DE
Neurodevelopment and Plasticity in Social Neural Circuits
$1,198,444David A Leopold · National Institute Of Mental Health · ZIA · FY2024 · MH
Gene Therapy for Urea Cycle Disorders
$1,198,336James M Wilson · University Of Pennsylvania · P01 · FY2011 · HD
Environmental and Genetic Risk Factors For Breast Cancer: The Sister Study
$1,198,324Dale P Sandler · National Institute Of Environmental Health Sciences · ZIA · FY2012 · ES
First-in-class TREM-1 inhibitors in combination therapy for pancreatic cancer
$1,198,246Alexander B Sigalov · Signablok, Inc. · R44 · FY2020 · CA
Nonviral Gene Medicine for Hemophilia A
$1,198,239Carol H Miao · Seattle Children'S Hospital · R01 · FY2009 · HL
Therapeutic targets in African-American youth with type 2 diabetes
$1,198,228Stephanie Therese Chung · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2020 · DK
GENE TRANSFER PROGRAM IN HEART, LUNG, AND BLOOD DISEASE
$1,198,037Brigham And Women'S Hospital · P50 · FY2001 · HL
The Efficacy and Safety of a Selective Estrogen Receptor Beta agonist (LY500307)
$1,198,036Alan Breier · Indiana University Indianapolis · UH3 · FY2014 · TR
Novel Molecular Therapies of Prostate Cancer
$1,197,703Dario C. Altieri · Wistar Institute · P01 · FY2014 · CA
Cell Prep Core
$1,197,564John Wunderlich · Division Of Basic Sciences - Nci · ZIC · FY2011 · CA
Cell Production Facility Core
$1,197,564Mark Dudley · Division Of Basic Sciences - Nci · ZIC · FY2011 · CA
Biology of memory
$1,197,552Ronald L Davis · University Of Florida · R35 · FY2022 · NS
Expansion of Cardiac and Hematopoietic Pregenitors by Wnt and Notch
$1,197,348Irwin Bernstein · Fred Hutchinson Cancer Research Center · U01 · FY2010 · HL
Immunologic Monitoring and Cellular Products Laboratory
$1,197,257Theresa L. Whiteside · University Of Pittsburgh At Pittsburgh · P30 · FY2020 · CA
Mechanisms of Effective Humoral Immune Responses to HIV-1
$1,197,237Mark Connors · National Institute Of Allergy And Infectious Diseases · ZIA · FY2023 · AI
The pathogenesis of facioscapulohumeral muscular dystrophy
$1,197,176Stephen J. Tapscott · Fred Hutchinson Cancer Research Center · P01 · FY2019 · NS
Epigenetic plasticity in tumor initiation and evolution
$1,197,000Bradley E Bernstein · Massachusetts General Hospital · DP1 · FY2017 · CA
Epigenetic plasticity in tumor initiation and evolution
$1,197,000Bradley E Bernstein · Massachusetts General Hospital · DP1 · FY2018 · CA
Epigenetic plasticity in tumor initiation and evolution
$1,197,000Bradley E Bernstein · Massachusetts General Hospital · DP1 · FY2016 · CA
Protein Modifications Involved in Cell Signaling
$1,196,889Aleksandra Nita-Lazar · National Institute Of Allergy And Infectious Diseases · ZIA · FY2025 · AI
Cellular and molecular mediators of fibrosis in the development of urinary tract dysfunction
$1,196,764William Ricke · University Of Wisconsin-Madison · U54 · FY2023 · DK
Process Development and Preclinical Advancement of a Novel Nanoparticle Formulation for Immune Activation
$1,196,731Richard Johnson · Saros Therapeutics Inc · R44 · FY2023 · CA
Molecular Pathogenesis of Basal-like Breast Cancer
$1,196,635Ramon E Parsons · Columbia University Health Sciences · P01 · FY2011 · CA